大血管闭塞前循环卒中低NIHSS评分患者的药物治疗与血管内治疗比较
该系统综述与Meta分析纳入11项观察性研究,比较血管内治疗联合最佳药物治疗与单纯最佳药物治疗对前循环大血管闭塞且入院NIHSS评分≤5的急性缺血性卒中患者的疗效。血管内治疗与3个月极佳功能结局无关(RR 1.10,95%CI 0.93-1.31),但症状性颅内出血风险更高(RR 3.53,95%CI 2.35-5.31);作者认为血管内治疗似乎等效于最佳药物治疗。
要点
- 低NIHSS评分前循环大血管闭塞患者中,EVT未改善3个月极佳功能结局(RR 1.10,95%CI 0.93-1.31)。
- EVT组症状性颅内出血风险显著高于BMT组(RR 3.53,95%CI 2.35-5.31)。
- EVT与3个月死亡率无关(RR 1.34,95%CI 0.83-2.18)。
核心结论
- 对于前循环大血管闭塞且基线NIHSS评分低的急性缺血性卒中患者,血管内治疗似乎等效于最佳药物治疗,尽管症状性颅内出血风险增加。
研究设计与样本
- 系统综述与Meta分析,检索MEDLINE、SCOPUS及参考文献列表至2022年12月28日,纳入11项观察性队列研究,共2019例接受EVT和3171例接受BMT的NIHSS评分≤5的前循环大血管闭塞急性缺血性卒中患者。
主要发现
- EVT与3个月极佳功能结局(mRS 0-1)无关(RR 1.10,95%CI 0.93-1.31)。
- 按研究设计(符合方案 vs 意向性治疗)分层,亚组间无显著差异。
- EVT与3个月良好功能结局(mRS 0-2)无关(RR 1.01,95%CI 0.89-1.16),与3个月残疾减少无关(common OR 0.92,95%CI 0.60-1.41)。
- 症状性颅内出血在EVT组更常见(RR 3.53,95%CI 2.35-5.31)。
- EVT与3个月死亡率无关(RR 1.34,95%CI 0.83-2.18);倾向性评分匹配研究的敏感性分析证实相同总体关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endovascular treatment (EVT) for acute ischemic stroke (AIS) patients presenting with National Institutes of Health Stroke Scale score of 0 to 5 is common in clinical practice but has not yet been proven safe and effective. Our objective is to assess whether EVT on top of best medical treatment (BMT) in AIS patients with large-vessel occlusion of the anterior circulation presenting with mild symptoms is beneficial compared with BMT. METHODS: We searched MEDLINE, SCOPUS, and reference lists of retrieved articles published until December 28, 2022. A systematic literature search was conducted to identify clinical trials or observational cohort studies evaluating patients with AIS due to anterior circulation large-vessel occlusion and admission National Institutes of Health Stroke Scale score ≤5 treated with EVT versus BMT alone. The primary outcome was excellent functional outcome (modified Rankin Scale score 0-1) at 3 months. The protocol had been registered before data collection (PROSPERO). RESULTS: Eleven observational eligible studies were included in the meta-analysis, comprising a total of 2019 AIS patients with National Institutes of Health Stroke Scale score ≤5 treated with EVT versus 3171 patients treated with BMT. EVT was not associated with excellent functional outcome (risk ratio, 1.10 [95% CI, 0.93-1.31]). When stratified for different study design (per-protocol versus intention-to-treat), there were no significant subgroup differences. EVT was not associated with good functional outcome (modified Rankin Scale score 0-2; risk ratio, 1.01 [95% CI, 0.89-1.16]) or reduced disability at 3 months (common odds ratio, 0.92 [95% CI, 0.60-1.41]). Symptomatic intracranial hemorrhage was more common in the patients receiving EVT (risk ratio, 3.53 [95% CI, 2.35-5.31]). No correlation was found between EVT and mortality at 3 months (risk ratio, 1.34 [95% CI, 0.83-2.18]). The same overall associations were confirmed in the sensitivity analysis of studies that performed propensity score matching. CONCLUSIONS: EVT appears equivalent to BMT for patients with anterior circulation large-vessel occlusion AIS with low baseline National Institutes of Health Stroke Scale, despite the increased risk for symptomatic intracranial hemorrhage. REGISTRATION: URL: https://www.crd.york.ac.uk/PROSPERO/; Unique identifier: CRD42022334417.
引用
- Safouris A, Palaiodimou L, Nardai S, et al. Medical Management Versus Endovascular Treatment for Large-Vessel Occlusion Anterior Circulation Stroke With Low NIHSS. Stroke. 2023. PMID: 37526011. doi:10.1161/STROKEAHA.123.043937
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。